top of page


CUREFIP.COM was conceived in the summer of 2019, shortly after a friend's cat was diagnosed with feline infectious peritonitis virus (FIPV). While drinking, we learned how emotionally devastating and deadly FIP can be, both for the cat and its owners. Our friend loved her cat like her children, and was devastated by the prognosis from two different doctors that FIP ​​is not treatable. All the doctors could offer to our friend was either steroid based anti-inflammatory medicine to temporarily reduce to suffering. We were also cat owners and became very concerned about our two cats Butter and Porky, so named not because they were fat, but because we liked to cook.

A few weeks later, we met this friend again for dinner. We were surprised to find her in a much better mood.  We naturally asked about her cat's condition. She told us she found an experimental treatment called GS-441524. Her cat was being treated on it for the past several weeks and was recovering well.  This really caught our curiosity. How can FIP, a disease that is supposedly impossible to cure according to two licensed veterinarians, be treated successfully by our friend who was without a license or medical qualifications?

So we started our own research and quickly learned from various sources that it was true what the doctors told our friend. There was no approved treatment for FIP infections on the market. However, there were 2 promising experimental treatments, GC-376 and GS-441524 that have demonstrated promising results in clinical trials completed in the USA and Europe. Although GC-376 showed promising initial responses in clinical trials, the infection recurrence rate was too high. Once reinfected, GC-376 proved to be ineffective controlling the infection a second time.


In contrast, GS-441524 was discovered by a group of researchers led by Dr. Niel Pedersen of the University of California, UC Davis. GS-441524, unlike GC-376, was shown to be even more effective in the treatment of FIP during the clinical trial, achieving an efficacy rate of well over 80% and a reinfection rate of less than 10%. What is even more impressive was that in the rare cases of reinfection, GS-441524 proved to be equally effective in subsequent treatments.  This drug was a nothing less than a breakthrough in the treatment of FIP. 

This is where the story took a sad turn. Although GS-441524 was found to be effective, no efforts was made to get it approved for animal use. People all over the world do not have access to this treatment for FIP.  Meanwhile, cats are dying needlessly around the world when FIP is now treatable. Doctors were unaware of the existence of this new experimental treatment due to a lack of information or were concerned about prescribing GS-441524 for fear of losing their professional licenses. Even when doctors was willing to prescribe GS-441524, they did not know where to obtain consistent quality supply.

We set out to resolve this issue. After speaking with several veterinary hospitals known to treat a large number of cases of FIP in China, we contacted two brands who agreed to supply us with GS-441524 for buyers outside of China. Slayer and Hua Hua. While their products were generally good, the volume, and concentration was inconsistent.  When we tested by independent labs, we found that the concentration from batch to batch could vary between 10-15mg/ml.  We needed to do better.  We began focusing our time on working with selecting and collaborating with our own contract manufacturer to create a product with more consistent quality standards. Today, we can proudly say that through our persistent efforts, we have help saved thousands of cats around the world, and the number is growing everyday.  Our GS-441524 are tested independently by internationally certified labs to ensure proper concentration, purity and volume as stated in our product description.  We ship to most global destinations in 3 days or less.  We are happy that we can make a living doing something good in this world. you can check our Government Legal Jurisdiction Here.

bottom of page